ArticleResearch square2026
Electroconvulsive therapy modulates neurite density and free water in discrete white matter compartments in major depression.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Electroconvulsive therapy (ECT) is the most effective treatment for severe or intractable depression. The disrupt-potentiate-rewire framework proposes that ECT's therapeutic effects include neural remodeling. We used the neurite orientation dispersion and density imaging (NODDI) model to characterize ECT-related longitudinal white matter (WM) microstructural changes. Fifty-two adults with treatment-resistant major depressive episodes (32 female) from two cohorts underwent multi-shell diffusion MRI and clinical assessment before the first ECT session and after completion of the index course. Plasma interleukin-6 (IL-6) was measured in one cohort. Linear mixed-effects models assessed longitudinal changes in neurite density, orientation dispersion, and free water across major WM tracts, with false-discovery-rate correction. Regression analyses examined relationships between WM changes, symptom improvement, and IL-6 change if available. Fractional anisotropy (FA) was also examined for comparison with prior studies. Depressive symptoms improved substantially, and IL-6 levels decreased following treatment. Neurite density, free water, and FA decreased across multiple frontolimbic pathways, including the uncinate fasciculus, external capsule, and internal capsule, whereas orientation dispersion remained unchanged. Free-water reductions were predominantly right-lateralized. In contrast to FA, greater NODDI-derived microstructural change was associated with greater depression symptom improvement across several mood-relevant pathways, while reductions in IL-6 showed trend-level associations with WM change. ECT was associated with coordinated reductions in neurite density and free water, alongside preserved fiber organization, within distributed WM pathways. These findings support microstructural remodeling during the putative rewiring phase of ECT and link WM change to both antidepressant improvement and changes in peripheral inflammation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.